구인두암의 치료 전략

키워드

참고문헌 (17)

1. Leon MB, "Human papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Med, 363(1), pp.24~35 (2010)
2. Chaturvedi AK, "Human papillomavirus and rising oropharyngeal cancer incidence in the United States", J Clin Oncol, 29(32), pp.4294~4301 (2011)
3. Shin A, "Trends of human papillomavirus-related head and neck cancers in Korea: National cancer registry data", Laryngoscope, 123(11), pp.E30~E37 (2013)
4. Ang KK, "A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome", J Clin Onco, 28(suppl), pp.15s~ (2010)
5. Fakhry C, "Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial", J Natl Cancer Inst, 100(4), pp.261~269 (2008)
6. Rischin D, "Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial", J Clin Oncol, 28(27), pp.4142~4148 (2010)
7. Posner MR, "Schumaker LM, Sarlis NJ, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial", Ann Oncol, 22(5), pp.1071~1077 (2011)
8. Lassen P, "Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck", J Clin Oncol, 27(12), pp.1992~1998 (2009)
9. Lassen P, "Danish Head and Neck Cancer Group (DAHANCA). The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial", Radiother Oncol, 100(1), pp.49~55 (2011)
10. Hafkamp HC, "Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas", Int J Cancer, 122(12), pp.2656~2664 (2008)
11. Weiss D, "Prevalence and impact on clinicopathological characteristics of human papillomavirus- 16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma", Head Neck, 33(6), pp.856~862 (2011)
12. Cohen MA, "Transoral robotic surgery and human papillomavirus status: oncologic results", Head Neck, s33(4), pp.573~580 (2011)
13. Marur S, "Eastern Cooperative Oncology Group E 1308: a phase II trial of induction chemotherapy (IC) followed by cetuximab with low dose versus standard dose IMRT in patients with human papilloma virus (HPV)-associated resectable squamous cell carcinoma of the oropharynx (OPSCC)", J Clin Oncol, 31(suppl) (2013)
14. Haddad RI, "The PARADIGM trial: a phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC)", J Clin Oncol, 30(suppl) (2012)
15. Cohen EE, "DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2", N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN), 2012, pp.30(suppl), ~
16. Ghi MG, "For the GSTTC Italian Study Group. A phase IIIII study comparing concomitant chemoradiotherapy (CRT) versus cetuximab", RT (CET, cisplatin, pp.5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826), J Clin Oncol[DOI]
17. Bonner JA, "Radiotherapy plus cetuximab for squamouscell carcinoma of the head and neck", N Engl J Med, 354(6), pp.567~578 (2006)

관련 논문AI추천